All posts tagged
“Alzheimer’s is the Last Unclaimed Therapeutic Space,” says TauRx exec
Biotech Targeting Tau-Tangles in Neurodegeneration Initiates Clinical Trials
Where Others Failed, a Vaccine for Dementia Shows Potential in the Clinic
More News! Allergan sees Patient Deaths, New Alzheimer’s Targets?
Can Roche & MorphoSys beat the odds in new Alzheimer’s Phase III Trials?
This Spanish Biotech is Detecting Alzheimer’s before Symptoms Appear
Hopes are up: A Second Phase III Trial for Alzheimer’s Disease
French Biotech bids for Crowdfunding in Neurodegenerative Disease
A Dutch University Hospital has Halted Amyloid Beta Drug Studies
10 Hot European Biotechs to Observe in 2017 🚀
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
The 8 Biggest Biotech Medical Fails of 2016 in Europe
Labiotech UG, All Rights Reserved -
Send this to friend